"New" Infectious Diseases: Successful Vaccine Developments At Themis Bioscience

Pasteur Institute Technology Proves its Effective Potential The Viennese biotech boutique Themis has reported rapid progress in the development of two highly efficient vaccines against Dengue and Chikungunya fever. In the just concluded preclinical studies, the two vaccine candidates, based on a technology by the Parisian Pasteur Institute, displayed exceedingly good efficacy. With a single vaccination against Chikungunya it was possible to develop full vaccination protection. The Dengue fever vaccine candidate proved effective against all of the four known serotypes of this infection...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news